Tobacco company's understanding of addiction revealed by internal documents

May 1, 2018, Public Library of Science
From the mid-1990s to at least 2006, a tobacco company's internal models of addiction regarded psychological, social, and environmental factors as comparable in importance to nicotine in driving cigarette use. Credit: Pixabay

After decades denying the role of nicotine dependence in smoking addiction, tobacco company Philip Morris (PM) publicly embraced nicotine as the main driver of smoking behavior in 2000. However, their internal understanding of smoking addiction was more complex, and the company simultaneously promoted nicotine reduction products alongside advertising and policy campaigns to promote smoking behavior, according to a new study published this week in PLOS Medicine.

The research, by Jesse Elias, Yogi Hendlin, and Pamela Ling of the University of California, San Francisco, analyzed previously secret, internal PM documents made available as a result of litigation against the tobacco industry to explore the company's understanding of before and after publicly admitting nicotine's addictiveness.

The researchers found that PM continued studying addiction through the 2000s to develop successful and potentially safer nicotine products, and that from the mid-1990s to at least 2006, Philip Morris's internal models of addiction regarded psychological, social, and environmental factors as comparable in importance to nicotine in driving cigarette use.

Elias and colleagues argue that PM's outward support for nicotine's role in driving allowed the company to redirect policy away from proven social and environmental interventions and toward the promotion of potentially reduced harm industry products.

The researchers note that due to the fragmented and incomplete nature of the tobacco industry documents archive, some relevant documents may have been missed. Nevertheless, the authors emphasize that reducing smoking prevalence requires policies that address all of the factors driving smoking addiction— e.g., advertising restrictions, plain packaging, tobacco taxes, and widespread smoke-free restrictions.

The authors say: "As PM's internal research indicates, positive health outcomes are more likely to be achieved by complementing NRT and behavioral counseling with ever-stronger society-level interventions addressing the psychological, social, and environmental components of addiction."

The authors have declared that no competing interests exist.

Explore further: National poll: Many unaware of court findings against tobacco companies

More information: Elias J, Hendlin YH, Ling PM (2018) Public versus internal conceptions of addiction: An analysis of internal Philip Morris documents. PLoS Med 15(5): e1002562. doi.org/10.1371/journal.pmed.1002562

Related Stories

National poll: Many unaware of court findings against tobacco companies

November 7, 2017
On Nov. 26, Altria, Philip Morris USA, R.J. Reynolds and other tobacco companies will begin to publish court-ordered "corrective statements" about cigarettes, the result of a 2006 federal court verdict that found the companies ...

Running away from addiction: How exercise aids smoking cessation

December 20, 2017
New research in mice sheds light on the mechanism underlining exercise's protective effect against nicotine dependence and withdrawal.

Investigators compare effects of nicotine with and without menthol on brain and behavior

November 16, 2017
A new study from UMass Medical School researchers at the Center for Comparative Neuroimaging explores the link between mentholated tobacco and nicotine addiction. They found that menthol administered with nicotine alters ...

Understanding the role of genes in smoking addiction, nicotine withdrawal

October 18, 2016
Thomas Gould hopes to better understand how genes influence nicotine-withdrawal symptoms in order to develop more effective smoking cessation programs.

Study shows cigarette makers shifted stance on nicotine patches, gum

August 17, 2017
The use of nicotine patches, gum, lozenges, inhalers or nasal sprays—together called "nicotine replacement therapy," or NRT—came into play in 1984 as prescription medicine, which when combined with counseling, helped ...

New method measures nicotine delivery from e-cigarettes

March 22, 2016
The effectiveness of e-cigarettes as a smoking substitute will likely rely on whether they can consistently provide the amount of nicotine a smoker needs to resist the desire to return to traditional cigarettes.

Recommended for you

Sitting for long hours found to reduce blood flow to the brain

August 20, 2018
A team of researchers with Liverpool John Moores University in the U.K. has found evidence of reduced blood flow to the brain in people who sit for long periods of time. In their paper published in the Journal of Applied ...

E-cigarettes can damage DNA

August 20, 2018
The popularity of electronic cigarettes continues to grow worldwide, as many people view them as a safer alternative to smoking. But the long-term effects of e-cigarette usage, commonly called "vaping," are unknown. Today, ...

Students more likely to eat school breakfast when given extra time, new study finds

August 18, 2018
Primary school students are more likely to eat a nutritional breakfast when given 10 extra minutes to do so, according to a new study by researchers at Virginia Tech and Georgia Southern University.

Like shark attack and the lottery, unconscious bias influences cancer screening

August 17, 2018
What do shark attack, the lottery and ovarian cancer screening having in common? It turns out our judgments about these things are all influenced by unconscious bias.

Phantom odors: One American in 15 smells odors that aren't there, study finds

August 16, 2018
Imagine the foul smell of an ash tray or burning hair. Now imagine if these kinds of smells were present in your life, but without a source. A new study finds that 1 in 15 Americans (or 6.5 percent) over the age of 40 experiences ...

US drug overdose deaths surge amid fentanyl scourge

August 16, 2018
US drug overdose deaths surged to nearly 72,000 last year, as addicts increasingly turn to extremely powerful synthetic opioid fentanyl as the supply of prescription painkillers has tightened.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.